Intravitreal Ziv-Aflibercept versus Bevacizumab for Naïve Central Retinal Vein Occlusion with Macular Edema: An Interim Analysis of a Randomized Non-Inferiority Trial

Overview of attention for article published in Clinical Ophthalmology, September 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,306 followers.

Confira nossa análise de um ensaio de não inferioridade randomizado, comparando o Ziv-Aflibercept intravítreo ao Bevacizumab para oclusão da veia retiniana central com edema macular. Acesse o artigo completo aqui: https://t.co/CHEVBtBfPi

18 Sep 2023

Reply Repost Favourite

Ophthopedia Update: Intravitreal Ziv-Aflibercept versus Bevacizumab for Naïve Central Retinal Vein Occlusion with Macular Edema: An Interim Analysis of a Randomized Non-Inferiority Trial #Ophthomology #Eye #Ophthotwitter https://t.co/3HT2ApJXZg https://t.c

18 Sep 2023

Reply Repost Favourite

Dove Medical Press

Article Metrics

Intravitreal Ziv-Aflibercept versus Bevacizumab for Naïve Central Retinal Vein Occlusion with Macular Edema: An Interim Analysis of a Randomized Non-Inferiority Trial

Mentioned by

Readers on